ATE111353T1 - Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen. - Google Patents

Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.

Info

Publication number
ATE111353T1
ATE111353T1 AT90908603T AT90908603T ATE111353T1 AT E111353 T1 ATE111353 T1 AT E111353T1 AT 90908603 T AT90908603 T AT 90908603T AT 90908603 T AT90908603 T AT 90908603T AT E111353 T1 ATE111353 T1 AT E111353T1
Authority
AT
Austria
Prior art keywords
treatment
macrolids
reversible obstructive
obstructive airway
airway diseases
Prior art date
Application number
AT90908603T
Other languages
English (en)
Inventor
Alan Anthony Norris
Dale Michael Jackson
Sohei Makino
Takeshi Fukuda
Ikuo Akutsu
Original Assignee
Fisons Plc
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898912935A external-priority patent/GB8912935D0/en
Priority claimed from JP2096045A external-priority patent/JPH03291225A/ja
Application filed by Fisons Plc, Fujisawa Pharmaceutical Co filed Critical Fisons Plc
Application granted granted Critical
Publication of ATE111353T1 publication Critical patent/ATE111353T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT90908603T 1989-06-06 1990-06-06 Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen. ATE111353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912935A GB8912935D0 (en) 1989-06-06 1989-06-06 Method of treatment
JP2096045A JPH03291225A (ja) 1990-04-09 1990-04-09 抗喘息薬

Publications (1)

Publication Number Publication Date
ATE111353T1 true ATE111353T1 (de) 1994-09-15

Family

ID=26295442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908603T ATE111353T1 (de) 1989-06-06 1990-06-06 Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.

Country Status (13)

Country Link
EP (1) EP0475994B1 (de)
JP (1) JP2508918B2 (de)
KR (1) KR0147852B1 (de)
AT (1) ATE111353T1 (de)
AU (1) AU639460B2 (de)
CA (1) CA2054203C (de)
DE (1) DE69012560T2 (de)
DK (1) DK0475994T3 (de)
ES (1) ES2061043T3 (de)
GR (1) GR1000738B (de)
IE (1) IE64214B1 (de)
PT (1) PT94292B (de)
WO (1) WO1990014826A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
ES2154262T3 (es) * 1991-04-26 2001-04-01 Fujisawa Pharmaceutical Co Uso de compuestos macrolidos para enfermedades oculares.
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
EP1699456A1 (de) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Verwendung von makroliden zur behandlung oder prävention von luftflussobstruktion
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
KR102293890B1 (ko) * 2018-12-11 2021-08-27 주식회사 몰젠바이오 신규 화합물 및 이를 포함하는 발모 촉진용 조성물
CN113939519B (zh) * 2018-12-11 2025-02-14 莫尔根生物有限公司 促进毛发生长的新化合物及包含它们的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
GR900100428A (en) 1991-11-15
DE69012560D1 (de) 1994-10-20
KR920700638A (ko) 1992-08-10
GR1000738B (el) 1992-12-30
IE902002L (en) 1990-12-06
AU639460B2 (en) 1993-07-29
EP0475994A1 (de) 1992-03-25
JPH05503283A (ja) 1993-06-03
DK0475994T3 (da) 1995-01-09
WO1990014826A1 (en) 1990-12-13
JP2508918B2 (ja) 1996-06-19
PT94292B (pt) 1997-01-31
KR0147852B1 (ko) 1998-08-17
ES2061043T3 (es) 1994-12-01
PT94292A (pt) 1991-02-08
IE64214B1 (en) 1995-07-26
CA2054203A1 (en) 1990-12-07
CA2054203C (en) 2001-08-21
EP0475994B1 (de) 1994-09-14
DE69012560T2 (de) 1995-03-09
AU5721490A (en) 1991-01-07

Similar Documents

Publication Publication Date Title
DE69012560D1 (de) Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.
MX9701538A (es) Sales de un derivado del indol contra la migraña.
TW243449B (de)
DE3570437D1 (en) 1-hydroxy-1,1-diphosphonic-acid derivatives, process for their preparation and pharmaceutical preparations, especially for the treatment of bone tumours
DE69704057D1 (de) Terphenylverbindungen und sie enthaltende arzneimittel
DK196688A (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
NO940777L (no) Anvendelse av et pregnanderivat
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
AU655869B2 (en) An amphoteric tricyclic compound
AU6690190A (en) New thiophene derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
AU625238B2 (en) Anti-psychotic piperidylbenzimidazole compounds
DE3261515D1 (en) Benzopyranyl ethers, process for their preparation and medicine containing those compounds and intermediates
DE69907387D1 (de) Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von refraktärer Vasculitis.
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
IE780926L (en) Chromene derivatives
JPS55122767A (en) Imidazole derivative*its manufacture and medical composition containing it
HUT62890A (en) Process for producing benzothiazole derivatives and pharmaceutical compositions comprising such compounds
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
MX9601163A (es) Nuevos compuestos derivados de cromeno.
EP1291349A4 (de) Malto-oligosaccharide und deren verwendung
GR3017801T3 (en) Flavone derivatives.
ATE109485T1 (de) Derivate von n-(vincristinyl-23) und n- (noranhydro-5-vinblastinyl-23) von amino-1- methylphosphonsäure, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
JPS57139083A (en) Cephalosporin derivative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee